JPWO2023028564A5 - - Google Patents

Info

Publication number
JPWO2023028564A5
JPWO2023028564A5 JP2024513015A JP2024513015A JPWO2023028564A5 JP WO2023028564 A5 JPWO2023028564 A5 JP WO2023028564A5 JP 2024513015 A JP2024513015 A JP 2024513015A JP 2024513015 A JP2024513015 A JP 2024513015A JP WO2023028564 A5 JPWO2023028564 A5 JP WO2023028564A5
Authority
JP
Japan
Prior art keywords
alkyl
halo
pharmaceutically acceptable
acceptable salt
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024513015A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024534840A5 (https=
JP2024534840A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/075472 external-priority patent/WO2023028564A1/en
Publication of JP2024534840A publication Critical patent/JP2024534840A/ja
Publication of JP2024534840A5 publication Critical patent/JP2024534840A5/ja
Publication of JPWO2023028564A5 publication Critical patent/JPWO2023028564A5/ja
Pending legal-status Critical Current

Links

JP2024513015A 2021-08-26 2022-08-25 Kif18aのスピロインドリン阻害剤 Pending JP2024534840A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163237275P 2021-08-26 2021-08-26
US63/237,275 2021-08-26
US202263306452P 2022-02-03 2022-02-03
US63/306,452 2022-02-03
US202263344435P 2022-05-20 2022-05-20
US63/344,435 2022-05-20
PCT/US2022/075472 WO2023028564A1 (en) 2021-08-26 2022-08-25 Spiro indoline inhibitors of kif18a

Publications (3)

Publication Number Publication Date
JP2024534840A JP2024534840A (ja) 2024-09-26
JP2024534840A5 JP2024534840A5 (https=) 2025-08-26
JPWO2023028564A5 true JPWO2023028564A5 (https=) 2025-08-26

Family

ID=83457176

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024513015A Pending JP2024534840A (ja) 2021-08-26 2022-08-25 Kif18aのスピロインドリン阻害剤

Country Status (12)

Country Link
US (2) US12084420B2 (https=)
EP (1) EP4392407A1 (https=)
JP (1) JP2024534840A (https=)
KR (1) KR20240109977A (https=)
CN (1) CN119241504A (https=)
AU (1) AU2022334480A1 (https=)
CA (1) CA3230123A1 (https=)
CL (1) CL2024000560A1 (https=)
IL (1) IL310863A (https=)
MX (1) MX2024002391A (https=)
TW (1) TW202317092A (https=)
WO (1) WO2023028564A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI844602B (zh) 2018-12-20 2024-06-11 美商安進公司 Kif18a抑制劑
TW202416973A (zh) 2022-08-18 2024-05-01 美商雅客森醫療公司 Kif18a抑制劑及其用途
WO2024066986A1 (zh) * 2022-09-30 2024-04-04 楚浦创制(武汉)医药科技有限公司 2-氨基嘧啶类化合物及其应用、药用组合物
CN120202002A (zh) * 2022-11-30 2025-06-24 微境生物医药科技(上海)有限公司 一种用于癌症治疗的药物组合物
EP4669309A1 (en) * 2023-02-23 2025-12-31 Volastra Therapeutics, Inc. SOLID FORMULATIONS AND POLYMORPHIC FORMS OF KIF18A INDOLIN INHIBITORS
WO2024188338A1 (zh) * 2023-03-16 2024-09-19 微境生物医药科技(上海)有限公司 Kif18a抑制剂
CN121909029A (zh) 2023-06-14 2026-04-21 沃拉斯查疗法公司 用kif18a的吲哚啉抑制剂治疗癌症的方法
WO2025190325A1 (zh) * 2024-03-13 2025-09-18 海南先声再明医药股份有限公司 Kif18a抑制剂和微管蛋白抑制剂的药物组合及用途

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1087725C (zh) 1994-03-25 2002-07-17 同位素技术有限公司 用氘代方法增强药物效果
US6334997B1 (en) 1994-03-25 2002-01-01 Isotechnika, Inc. Method of using deuterated calcium channel blockers
US6534309B1 (en) 2000-08-03 2003-03-18 Cytokinetics, Inc. Motor proteins and methods for their use
AU2002231098A1 (en) 2000-12-15 2002-06-24 Emory University Nonpeptide agonists and antagonists of vasopressin receptors
WO2004039774A2 (en) 2002-05-23 2004-05-13 Merck & Co., Inc. Mitotic kinesin inhibitors
EP2305812A3 (en) 2002-11-14 2012-06-06 Dharmacon, Inc. Fuctional and hyperfunctional sirna
US7423018B2 (en) 2002-12-13 2008-09-09 University Of Massachusetts Kinesin-like proteins and methods of use
AU2004264533B2 (en) 2003-08-15 2009-01-22 Merck Sharp & Dohme Corp. Mitotic kinesin inhibitors
US7504413B2 (en) 2004-05-06 2009-03-17 Cytokinetics, Inc. N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
KR101170925B1 (ko) 2004-06-18 2012-08-07 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 암 치료용 키네신 방추 단백질 (ksp) 억제제로서의n-(1-(1-벤질-4-페닐-1h-이미다졸-2-일)-2,2-디메틸프로필)벤자미드 유도체 및 관련 화합물
ATE486878T1 (de) 2004-08-18 2010-11-15 4Sc Ag Benzothienopyridine zur verwendung als inhibitoren von eg5-kinesin
US7829296B2 (en) 2005-04-25 2010-11-09 Ramot At Tel-Aviv University Ltd. Kinesin polypeptides, polynucleotides encoding same and compositions and methods of using same
JP2009514866A (ja) 2005-11-02 2009-04-09 サイトキネティクス・インコーポレーテッド ある種の化学物質、組成物、および方法
WO2008007122A2 (en) 2006-07-14 2008-01-17 Astex Therapeutics Limited Combinations of pyrazole derivatives for the inhibition of cdks and gsk's
US20080051463A1 (en) 2006-08-04 2008-02-28 Aeterna Zentaris Gmbh Anthracene compounds and their use for treating benign and malignant tumor disorders
AR062200A1 (es) 2006-08-04 2008-10-22 Aeterna Zentaris Gmbh Derivados de antraceno y su uso para el tratamiento de emfermedades tumorales bengnas y malingnas
AR077033A1 (es) 2009-06-11 2011-07-27 Hoffmann La Roche Compuestos inhibidores de las quinasas de janus y su uso en el tratamiento de enfermedades inmunologicas
EP2295543A1 (en) 2009-09-11 2011-03-16 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for the preparation of an influenza virus
WO2011085261A1 (en) 2010-01-08 2011-07-14 Selexagen Therapeutics, Inc. Hedgehog inhibitors
JP5111626B2 (ja) 2011-01-14 2013-01-09 Ntn株式会社 電動シートリクライニング用ころ軸受
CN102796103A (zh) 2011-05-23 2012-11-28 南京英派药业有限公司 6-(芳基甲酰)咪唑并[1,2-a]嘧啶和6-(芳基甲酰)[1,2,4]三唑并[4,3-a]嘧啶作为Hedgehog抑制剂及其应用
WO2013188600A1 (en) 2012-06-12 2013-12-19 Washington University Copy number aberration driven endocrine response gene signature
JP6098406B2 (ja) 2013-07-17 2017-03-22 Jfeスチール株式会社 溶接接合部および溶接接合方法
PT3031799T (pt) 2013-08-09 2018-07-04 Takeda Pharmaceuticals Co Composto aromático
WO2015183776A1 (en) 2014-05-29 2015-12-03 Merck Sharp & Dohme Corp. Methods for treating cancer with a wee1 inhibitor
WO2016100882A1 (en) 2014-12-19 2016-06-23 Novartis Ag Combination therapies
TW201643139A (zh) * 2015-04-17 2016-12-16 佛瑪治療公司 作為組蛋白脫乙醯基酶抑制劑之3-螺環-6-異羥肟酸萘滿
WO2016177340A1 (zh) 2015-05-05 2016-11-10 上海海雁医药科技有限公司 双环取代的苯磺酰胺衍生物、其制法与医药上的用途
TW202523682A (zh) 2015-05-20 2025-06-16 美商博德研究所有限公司 共有之gata3相關之腫瘤特異性新抗原
AU2017236431A1 (en) 2016-03-24 2018-09-27 Bayer Pharma Aktiengesellschaft Prodrugs of cytotoxic active agents having enzymatically cleavable groups
SG11202000132WA (en) 2017-07-10 2020-02-27 Univ Cornell Targeting chromosomal instability and downstream cytosolic dna signaling for cancer treatment
WO2019140380A1 (en) 2018-01-12 2019-07-18 Kymera Therapeutics, Inc. Protein degraders and uses thereof
CN108768023B (zh) 2018-08-13 2020-01-07 珠海格力电器股份有限公司 转子组件及交替极电机
DE102018213662A1 (de) 2018-08-14 2020-02-20 Robert Bosch Gmbh Lautsprecher mit einem darin enthaltenen Leuchtelement
CN109039072B (zh) 2018-08-21 2020-09-08 南京南瑞继保电气有限公司 一种双极双向直流变换器及其控制方法和控制装置
JP7676308B2 (ja) * 2018-12-20 2025-05-14 アムジエン・インコーポレーテツド Kif18a阻害剤として有用なヘテロアリールアミド
WO2020132651A1 (en) * 2018-12-20 2020-06-25 Amgen Inc. Kif18a inhibitors
EP3898616B1 (en) * 2018-12-20 2024-10-02 Amgen Inc. Heteroaryl amides useful as kif18a inhibitors
TWI844602B (zh) 2018-12-20 2024-06-11 美商安進公司 Kif18a抑制劑
EP4600650A3 (en) 2019-04-05 2025-11-26 Earli Inc. Improved methods and compositions for synthetic biomarkers
CN113785076B (zh) 2019-05-03 2024-06-11 株式会社递希真 预测癌症预后的方法及其组合物
WO2021011634A1 (en) 2019-07-15 2021-01-21 Kymera Therapeutics, Inc. Protein degraders and uses thereof
AU2020326627B2 (en) * 2019-08-02 2026-01-29 Amgen Inc. KIF18A inhibitors
EP4007756B1 (en) * 2019-08-02 2025-12-24 Amgen Inc. Kif18a inhibitors
WO2021026099A1 (en) 2019-08-02 2021-02-11 Amgen Inc. Kif18a inhibitors
US12540129B2 (en) * 2019-08-02 2026-02-03 Amgen Inc. KIF18A inhibitors
WO2021161323A1 (en) 2020-02-16 2021-08-19 Genetikaplus Ltd. Methods of therapeutic prognostication
US12187992B2 (en) 2020-02-19 2025-01-07 The Regents Of The University Of California Method and device for early cancer screening
JP2023521802A (ja) 2020-04-14 2023-05-25 アムジエン・インコーポレーテツド 新生物疾患の処置のためのkif18a阻害剤
US20230233565A1 (en) 2020-05-11 2023-07-27 University Of Vermont A treatment approach involving kif18a inhibition for chromosomally unstable tumors
WO2022032073A2 (en) 2020-08-07 2022-02-10 Casma Therapeutics, Inc. Trpml modulators
EP4319821A1 (en) 2021-04-09 2024-02-14 Nanjing University Conjugate and the preparing method and use thereof
CN113528509A (zh) 2021-06-01 2021-10-22 释科生物科技(广州)有限公司 一种用于预测胃癌免疫治疗的肿瘤微环境评分系统的构建方法以及分子探针
JP7773801B2 (ja) 2021-06-25 2025-11-20 ハンジョウ イノゲート ファーマ カンパニー リミテッド Kif18a阻害剤としての化合物
TW202321213A (zh) 2021-07-21 2023-06-01 美商安進公司 Kif18a抑制劑化合物之鹽和固態形式
CN115772159A (zh) 2021-09-06 2023-03-10 微境生物医药科技(上海)有限公司 Kif18a抑制剂
CN115785068A (zh) 2021-09-10 2023-03-14 微境生物医药科技(上海)有限公司 Kif18a抑制剂
WO2023041055A1 (zh) 2021-09-16 2023-03-23 微境生物医药科技(上海)有限公司 Kif18a抑制剂
US20230117405A1 (en) 2021-09-22 2023-04-20 Volastra Therapeutics, Inc. Systems and methods for evaluation of chromosomal instability using machine-learning
AU2022389558A1 (en) 2021-11-19 2024-05-23 Wigen Biomedicine Technology (shanghai) Co., Ltd. Kif18a inhibitor
JP2025515484A (ja) 2022-04-28 2025-05-15 ヴォラストラ セラピューティクス,インコーポレーテッド Kif18aを阻害するための化合物

Similar Documents

Publication Publication Date Title
JP7629580B1 (ja) ベンゾピリミジン化合物及びその使用
RU2435756C2 (ru) Избирательные андрогенные рецепторные модуляторы
JP4344234B2 (ja) タキソール増強剤化合物
JP7276719B2 (ja) 選択的HER2阻害剤としてのピロロ[2,1-f][1,2,4]トリアジン系誘導体及びその使用
JP2021523225A5 (https=)
ES2558087T3 (es) Procesos para la preparación de moduladores del receptor S1P1 y formas cristalinas de los mismos
WO2018008711A1 (ja) Ep4拮抗薬と免疫チェックポイント阻害薬を含んでなる組み合わせ
IL287159B2 (en) Small molecules agonists for FXR (farnesoid X receptor) and method for their preparation and use
JP2020063289A5 (https=)
JPWO2023028564A5 (https=)
TW202114985A (zh) Ep拮抗劑
JP2023100842A (ja) 置換フェニルスルホニルフェニルトリアゾールチオンおよびその使用法
JPWO2012036287A1 (ja) 新規コルチスタチンa類似体およびその用途
JP2005531563A5 (https=)
CN115244063B (zh) 过渡金属催化剂的配体
US10093609B2 (en) TAK1 kinase inhibitors, compositions, and uses related thereto
JP6854497B2 (ja) インドールアミン−2,3−ジオキシゲナーゼ阻害剤としてのスルホニルアミディーン及びその製造方法と用途
JPWO2019217890A5 (https=)
WO2023224128A1 (ja) 線維症の治療又は予防のための医薬組成物
JP2022519086A (ja) デゾシン誘導体及びその医療用途
JPWO2022257979A5 (https=)
WO2004087628A1 (en) An amino alcohol ligand and its use in preparation of chiral proparglic tertiary alkohols and tertiary amines via enantioselective additon reaction
JP2004359546A (ja) ヒドロキサム酸誘導体、それらの非毒性塩およびそれらのプロドラッグ体を有効成分として含有する、固形癌の予防および/または治療剤
JP7716980B2 (ja) エストロゲン受容体拮抗剤
WO2022063317A1 (zh) 稠合的三并环衍生物及其在药学上的应用